- Solvay agrees to acquire Fournier
- Lundbeck, Solvay to develop antipsychotic; ended
- Solvay, Wyeth end CNS candidate development partnership
- Abbott gets US rights to Group Fournier's fenofibrate
- UCB buys Celltech for £1.53bn in cash
- Pfizer marketing UCB's allergy antihistamine Zyrtec
- BMS and Solvay Pharmaceuticals develop obesity compound
- Solvay buys Unimed for $108.7mm in cash
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.